Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017

Vandael, Eline; Latour, Katrien; Goossens, Herman; Magerman, Koen; Drapier, Nico; Catry, Boudewijn; Versporten, Ann

doi:10.1186/s13756-019-0663-7

Antimicrobial Resistance & Infection Control

Table 4 Overview of the antimicrobial quality indicators, total results for Global and ECDC-PPS 2017 (Belgium, acute care hospitals)

From: Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017

	Targeted treatment		Targeted treatment (resistant MO)		Reason recorded		Stop or review date recorded		Parenteral administration		Guidelines available		Compliant to local guidelines
	N	%	N	%	N	%	N	%	N	%	N	%	N	%
All hospital sites	1242	37.0	226	6.7	7558	81.9	2093	40.8	5072	69.3	3686	88.4	2825	76.6
Per type of hospital^a
Primary	804	33.9	156	6.6	4754	83.2	1362	39.8	3280	69.3	2508	86.1	1935	77.2
Secondary	248	44.4	31	5.6	1860	84.8	480	53.0	1162	68.1	689	95.8	569	82.6
Tertiary	185	45.7	37	9.1	889	70.1	237	32.0	606	71.4	455	89.9	289	63.5
Ward specialty
Medicine	821	34.6	125	5.3	5007	84.5	1282	39.3	2911	62.4	2353	88.9	1820	77.3
Surgery	279	43.3	60	9.3	1726	73.3	600	45.8	1501	76.1	969	87.2	703	72.5
ICU	142	42.0	41	12.1	825	86.4	211	38.2	660	96.2	364	88.1	302	83.0
Indication
CAI	684	30.7	89	4.0	4308	90.2	1001	37.5	2647	68.0	2021	90.3	1626	80.5
HAI	523	51.1	129	12.6	2011	86.2	551	41.1	1250	71.4	911	86.7	713	78.3
LAI	35	34.7	8	7.9	231	93.1	64	53.8	137	68.2	92	89.3	76	82.6
MP	NA	NA	NA	NA	305	56.0	56	19.4	93	28.4	131	74.4	88	67.2
SP	NA	NA	NA	NA	640	61.7	377	82.3	859	89.5	414	91.6	303	73.2

ECDC European Centre for Disease Prevention and Control, CAI Community-acquired infections, HAI Healthcare-associated infections, ICU Intensive care unit, LAI Infection present on admission from long-term care facility or Nursing Home, MO Micro-organisms, MP Medical prophylaxis, N Number of prescriptions or patients, NA Not applicable, PPS Point prevalence survey, SP Surgical prophylaxis
^aResults of the specialized hospital (N = 1) not shown
Targeted treatment: only patients included in the Global-PPS and with at least one antibiotic medical (CAI, HAI, LAI) treatment (N = 3354)
Reason recorded: patients of the Global- and ECDC-PPS; all antimicrobial prescriptions included
Stop or review date recorded: only patients included in the Global-PPS; all antimicrobial prescriptions included
Parenteral administration: patients of the Global- and ECDC-PPS; patients who received at least one parenteral antibiotic for systemic use over all patients who received at least one antibiotic for systemic use
Guidelines available: only patients included in the Global-PPS; antibiotic prescriptions for which guidelines were available, count at patient level and diagnosis (for combination therapy: no guidelines available for ≥1 antibiotic = no guideline for combination)
Compliant to local guidelines: only patients included in the Global-PPS; antibiotic prescriptions for which guidelines were available used as denominator, count at patient level and diagnosis (for combination therapy no compliance for ≥1 antibiotic = combination not compliant)

Back to article page

ISSN: 2047-2994

Contact us

General enquiries: journalsubmissions@springernature.com